HCPLive

Rheumatoid Arthritis 
The MD Magazine Rheumatoid Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Sponsored

ACR Proposes Recommendations for Glucocorticoid-Induced Osteoporosis
Used for treatment of inflammation in rheumatic diseases, glucocorticoids are known to cause osteoporosis. The American College of Rheumatology has put forth new recommendations to hopefully decrease the frequency of bone fractures.
Prescribing rheumatologists discussed drug interactions, costs, contraindications, and severity of side effects with less than 50% of the patients in the study to whom they had prescribed disease-modifying antirheumatic drugs.
With ever-growing data that the inflammation in rheumatic conditions can go hand-in-hand with cardiovascular inflammation, two different studies seek to broaden rheumatology’s approach to dangerous conditions it may influence.
Researchers who evaluated adverse events in a large sample of patients taking NSAIDs for arthritis came to a surprising conclusion: celecoxib is the safest of three drugs studied.
Certain types of inflammation go hand-in-hand. Columbia University researchers hypothesized that treatment that lowered arthritis disease activity would also decrease the risk of heart failure.
Researchers from the UK say they have developed a blood test that can detect osteoarthritis and rheumatoid arthritis long before painful symptoms become noticeable.
Sirukumab, a rheumatoid arthritis treatment that has performed well in recent studies, is now awaiting approval in both the United States and Europe.
The FDA today approved its fourth biosimilar, a tumor necrosis factor inhibitor similar to adalimumab.
A group of researchers from Pfizer found that its biosimilar version of rituximab yielded similar clinical responses in patients with rheumatoid arthritis compared with the innovator product Rituxan.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$